Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Volatile Stock Indices require careful risk management and agile tactics. This view helps you adapt strategies to sudden price moves and liquidity shifts.
19,564 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Oil prices jumped as traders priced a roughly four-week disruption to supply. Goldman Sachs analysts say the move ref...
Artificial intelligence is reshaping medicine, from drug discovery to patient care. This article spotlights two healt...
Barclays just boosted its Oracle price target to $240, highlighting a sharper focus on Oracle's cloud expansion and A...
A focused look at OmniAb's Q4 2025 earnings and what the numbers could mean for investors. Discover the drivers, risk...
CF Industries has surged this year on supply constraints and cost advantages, yet a DOJ probe adds regulatory risk th...
Robinhood enters 2026 with expanded features and crypto access, while scrutiny tightens around fees and security. Thi...
A Russian actor allegedly used forged ties to the Astor name to extract roughly $450 million from a Mexican billionai...
Warner Bros Discovery's 2026 earnings call transcript offers more than quarterly figures. This analysis breaks down t...
A fresh Mizuho note raises Intel's price target to $124 on AI server demand, signaling renewed confidence in the turn...
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...
Elite investors are reorganizing their portfolios, and big names like bill ackman these super are making strategic be...